Total Funding
38
31
Total FundingVenture - Series Unknown raised
Growth Score
-1 pts
Heat Score
13 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
282020
Photolitec develops photosensitizing compounds for image-guided photodynamic therapy.
- Ravindra K. Pandey: Founder and CSO
Thomas P. Stewart: President & CCO
About the Company
A spin-off of Roswell Park Cancer Institute (RPCI), Photolitec is a new life-sciences company developing photosensitizing compounds for image-guided photodynamic therapy (PDT). PDT is an innovative cancer treatment pioneered at RPCI's Photodynamic Therapy Center.
The compounds that Photolitec is working to commercialize were developed
primarily by Ravindra Pandey, Ph.D. while at RPCI. Dr. Pandey is a Distinguished Member of the PDT Center and Director of Pharmaceutical Chemistry at RPCI, and is the founder and Chief Scientific Officer of Photolitec.
